57
Growth Score in past quarter
pts
Heat Score 57 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
252938
StemWave offers non-invasive pain relief technology using Cellular Response Technology for chronic and acute pain treatment.
- Tom Kostopoulos: CEO & Founder
- Antonio Bruni: CMO & Co-Founder
About the Company
StemWave develops and introduces medical technology aimed at reshaping traditional healthcare. The company's main product, StemWave™, offers a non-invasive treatment for chronic and acute pain in areas such as knees, shoulders, back, and feet. Utilizing Cellular Response Technology and precise biofeedback, the treatment provides 80-95%
improvement for qualified patients. The device is FDA listed, easy to use, and features a wider treatment zone with 5-10 minute sessions. StemWave also offers clinical training modules, online support, and device repair services to ensure effective implementation in clinics.